This paper discusses a model for optimising the screening of prison inmates, and vaccinating them against hepatitis B infection. Hepatitis B and other blood borne infections are common in prison populations worldwide because of previous or current intravenous drug use and unprotected sexual intercourse. Preliminary Ã Â½ findings from the implementation of the model described in New SouthWales prison settings highlight its signiÃ Â½ficant potential for enhancing clinical accountability, as well as improving systems for vaccinating prison inmates. It is however inadequate for optimising sero-conversion, or vaccination follow-up, rates.Such aspects require concurrent adoption of complementary models.
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : May 20, 2019